It's one of the things that I like about this drug, and the Acne formulation as well for that matter which I maintain is the real revenue giant if approved, is they don't cure the problem. They only treat the symptoms. So if this formulation works as intended for x% of the population then logic dictates most should return and the patient base will consistently grow as new prospective patients are born and are afflicted with the condition - Long term view.
Acne is the one I am most exited for - the target population is massive and it hit's the cosmetic / vanity sweet spot that redefines the drug into a must have for basically anyone going through puberty and it's a self generating patient pool as everyone goes through puberty and a high % of people suffer acne during that time.
Probably a rather callous point of view from the patients perspective but from a Revenue perspective ...........
- Forums
- ASX - By Stock
- BOT
- BOT - Anything but charting
BOT - Anything but charting, page-8469
-
- There are more pages in this discussion • 2,209 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
40.5¢ |
Change
-0.010(2.41%) |
Mkt cap ! $734.6M |
Open | High | Low | Value | Volume |
42.0¢ | 42.5¢ | 39.5¢ | $3.680M | 8.989M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
18 | 297011 | 40.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
40.5¢ | 12027 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 292011 | 0.400 |
15 | 448461 | 0.395 |
6 | 156017 | 0.390 |
9 | 94706 | 0.385 |
15 | 342471 | 0.380 |
Price($) | Vol. | No. |
---|---|---|
0.405 | 12027 | 3 |
0.410 | 278359 | 4 |
0.415 | 245758 | 5 |
0.420 | 204502 | 9 |
0.425 | 336469 | 7 |
Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |